Healthcare/Pharmaceuticals Analysts discuss the Catalent (CTLT) and Novo Nordisk (NVO) transaction on an Analyst/Industry conference call to be held on March 15.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CTLT:
- Piper Sandler healthcare/pharma analysts hold analyst/industry conference call
- William Blair healthcare analysts hold analyst/industry conference call
- A New Cause for Concern: Catalent Inc Adds a New Share Price & Shareholder Rights Risk
- Catalent to delay 10-Q filing
- Catalent price target raised to $63.50 from $56 at Baird
